Sharekhan

Acutaas Chemicals Ltd

Mon 18/05/2026,15:55:17 | NSE : ACUTAAS

₹ 2799.1068.10 (2.49%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 2725.00

Previous Close

₹ 2731.00

Volume

352410

Mkt Cap ( Rs. Cr)

₹22916.55

High

₹ 2818.70

Low

₹ 2714.50

52 Week High

₹ 2849.90

52 Week Low

₹ 1059.00

Book Value Per Share

₹ 185.64

Dividend Yield

0.00

Face Value

₹ 5.00

What’s Your Call?

Collective community sentiment on Acutaas Chemicals Ltd

Your Vote -

Buy

38.89%

Hold

27.16%

Sell

33.95%

38.89%

162 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

2799.10

95

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

95

Option Chain

Analyzes market sentiment, predicts Acutaas Chemicals Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Acutaas Chemicals - Announcement under Regulation 30 (LODR)-Investor Presentation

    16 May 2026, 1:07PM Corporate Presentation which shall be discussed at the upcoming Investor Conferences/Meets is herewith enclosed.
  • Acutaas Chemicals - Analysts/Institutional Investor Meet/Con. Call Updates

    14 May 2026, 6:15PM Acutaas Chemicals Limited has informed the Exchange about Schedule of meet
  • Acutaas Chemicals - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    14 May 2026, 6:13PM Intimation of schedule of Conferences Meet as per details attached.
  • Acutaas Chemicals - Analysts/Institutional Investor Meet/Con. Call Updates

    6 May 2026, 10:46AM Acutaas Chemicals Limited has informed the Exchange about Transcript
  • Acutaas Chemicals - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    6 May 2026, 10:42AM Transcript of Earnings Call for Q4 FY26 Financial Results held on April 30, 2026 is enclosed.
  • Acutaas Chemicals - Copy of Newspaper Publication

    1 May 2026, 6:01PM Acutaas Chemicals Limited has informed the Exchange about Copy of Newspaper Publication
  • Acutaas Chemicals - Analysts/Institutional Investor Meet/Con. Call Updates

    30 Apr 2026, 7:18PM Acutaas Chemicals Limited has informed the Exchange about Link of Recording
  • Acutaas Chemicals - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    30 Apr 2026, 7:13PM Earnings Call Recording held on April 30, 2026 discussing the Q4 FY 26 financial results is herewith enclosed.
  • Acutaas Chemicals - General Updates

    30 Apr 2026, 5:38PM Acutaas Chemicals Limited has informed the Exchange about General Updates - Board approves Final Dividend
  • Acutaas Chemicals - Investor Presentation

    30 Apr 2026, 12:47PM Acutaas Chemicals Limited has informed the Exchange about Investor Presentation
  • Acutaas Chemicals - Press Release

    30 Apr 2026, 12:38PM Acutaas Chemicals Limited has informed the Exchange regarding a press release dated April 30, 2026, titled ""Q4 & FY26 Results"".
  • Acutaas Chemicals - Outcome of Board Meeting

    30 Apr 2026, 12:23PM Acutaas Chemicals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
  • Acutaas Chemicals - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

    30 Apr 2026, 5:11PM <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border='1px'><tr> <td><b>Sr. No.</b></td
  • Acutaas Chemicals - Corporate Action-Board approves Dividend

    30 Apr 2026, 3:42PM Board approved the final dividend of Rs. 2.5/- (at the rate of 50%) per equity share of Rs. 5/- each fully paid for the FY 2025-26 subject to approval
  • Acutaas Chemicals Q4 net profit zooms 118.09% at Rs 137.07 cr

    30 Apr 2026, 1:50PM The company reported standalone net profit of Rs 137.07 crore for the quarter ended March 31, 2026 as compared to Rs 62.85 crore in the same period la
  • Acutaas Chemicals - Announcement under Regulation 30 (LODR)-Investor Presentation

    30 Apr 2026, 12:46PM Investor Presentation on fourth quarter and year ended financial results as on March 31, 2026 is attached.
  • Acutaas Chemicals - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    30 Apr 2026, 12:41PM Press Release discussing the fourth quarter and year ended financial results as on March 31, 2026 is attached.
  • Acutaas Chemicals - Audited Standalone And Consolidated Financial Statement & Results For Fourth Quarter And Year Ended March

    30 Apr 2026, 12:22PM Audited standalone and consolidated financial results for the fourth quarter and year ended on March 31, 2026 is enclosed.
  • Acutaas Chemicals - Board Meeting Outcome for Outcome Of The Board Meeting Eld On April 30, 2026

    30 Apr 2026, 12:17PM The Board of Directors of the Company at their meeting held on Thursday , April 30, 2026, inter alia, considered & approved Audited Standalone & Cons
  • Acutaas Chemicals - Analysts/Institutional Investor Meet/Con. Call Updates

    27 Apr 2026, 2:30PM Acutaas Chemicals Limited has informed the Exchange about Schedule of meet
  • Acutaas Chemicals - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    27 Apr 2026, 2:23PM Intimation of Earnings Conference Call scheduled on Thursday, April 30, 2026 at 5.30 PM (IST) as per details attached.
  • Acutaas Chemicals - Corporate Action-Board to consider Dividend

    27 Apr 2026, 10:54AM Meeting of the Board of Directors is scheduled to be held on April 30, 2026 to interalia consider the recommendation of final dividend for the FY 2025
  • Acutaas Chemicals - Board Meeting Intimation for Approval Of Audited Standalone & Consolidated Financial Results For The Quar

    27 Apr 2026, 10:41AM Acutaas Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2026 ,inter alia, to consider an
  • Acutaas Chemicals has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026

    16 Apr 2026, 12:10PM As of March 2026, 32.66% is owned by Indian Promoters and 67.34% by Public. <p align=justify> Institutional holds 39.08% (Insurance Companies 3.25%) a
  • Acutaas Chemicals - Copy of Newspaper Publication

    14 Apr 2026, 6:57PM Acutaas Chemicals Limited has informed the Exchange about Copy of Newspaper Publication
  • Acutaas Chemicals - Disclosure under SEBI Takeover Regulations

    8 Apr 2026, 12:08PM Nareshkumar R. Patel and Chetankumar C. Vaghasia has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Excha
  • Acutaas Chemicals - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    2 Apr 2026, 6:09PM Acutaas Chemicals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Acutaas Chemicals - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    2 Apr 2026, 6:02PM Compliance Certificate under regulation 74(5) for the quarter ended March 31,2026 is attached
  • Acutaas Chemicals - Trading Window

    25 Mar 2026, 4:20PM Acutaas Chemicals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations
  • Acutaas Chemicals - Analysts/Institutional Investor Meet/Con. Call Updates

    2 Mar 2026, 12:01PM Acutaas Chemicals Limited has informed the Exchange about Schedule of meet
  • Acutaas Chemicals - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    2 Mar 2026, 11:56AM Intimation of schedule of Investor Meet
  • Ami Organics

    12 Dec 2024 , 1:31PM The company has approved an enhancement in capital expenditure amounting to a total cost of Rs 177 crores for its brownfield project focused on electrolyte additive products at the Jhagadia facility. his increase is attributed to the additional expenditure required for building dedicated ancillary infrastructure, which includes transforming manual operations into fully automated systems, as well as constructing dedicated utilities and storage and packaging facilities.
  • Ami Organics

    10 Jun 2024 , 10:28AM Ami Organics: Company says the inspection has concluded successfully on June 7, 2024 without any critical/major observation. (Positive)
  • Ami Organics

    4 Mar 2024 , 12:41PM The company gets patents for 2 inventions for 20 years. With this the total number of Patents granted to Company for its innovative processes and technology stands at 9. Positive for the stock
  • Ami Organics

    22 Dec 2023 , 11:41AM The company has signed a non-binding MOU with a global manufacturer of Electrolytes for manufacturing of electrolytes for battery cells and allied materials in Gujarat, India.
  • Ami Organics

    15 Dec 2023 , 11:27AM Company’s subsidiary has received a Letter of Award (LOA) worth Rs 1,026.31 crore for the appointment of advanced metering infrastructure service providers (AMISPs), including the design of advanced metering infrastructure (AMI) systems with supply, installation, and commissioning with an FMS of about a million smart prepaid metres, system metres, including DT metres, with corresponding energy accounting on a DBFOOT basis. Positive for the Stock
  • Ami Organics

    24 Apr 2023 , 10:15AM The company announced its foray into the semiconductor industry through acquisition of 55% stake in Baba Fine Chemicals (BFC) for a consideration of Rs68 crore (valued at 4x FY23 EV/EBITDA). BFC is engaged into manufacturing of specialty chemicals used in semiconductor and electronics industry). Positive read through for Ami Organics as BFC provides Ami Organics to tap growth opportunities in the lucrative and high entry barrier semiconductor industry.
  • Ami Organics

    28 Nov 2022 , 10:30AM The company has signed a definitive multi-year, multi-tonne agreement with Fermion, a fully owned subsidiary of Orion Corporation, Finland, for supply of an intermediate for its patented product. The total minimum contract value is expected to be multi-million Euro and will be spread across a 10-year period. The product is expected to start contributing meaningfully to the revenue from FY24. Positive read through for Ami Organics.
  • Ami Organics finalise capex plan of Rs. 190 cr

    29 Apr 2022 , 11:51AM Ami Organics finalised capex plan of Rs. 190 cr for Ankleshwar Unit to build a Brownfield Plant

Key fundamentals

Evaluate the intrinsic value of Acutaas Chemicals Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 1317.9442 877.8451 590.1441 518.848 281.1263
Liabilities 1317.9442 877.8451 590.1441 518.848 281.1263
Equity 40.9345 36.8806 36.4371 36.4371 31.5
Gross Profit 225.1423 107.6654 122.6615 105.1756 80.2023
Net Profit 159.5462 43.6849 83.3426 71.9461 53.9989
Cash From Operating Activities 115.9279 100.8477 55.728 -9.6915 26.3786
NPM(%) 16.11 6.35 13.51 13.83 15.85
Revenue 989.8346 687.5829 616.734 520.135 340.6078
Expenses 764.6923 579.9175 494.0725 414.9594 260.4055
ROE(%) 10.49 2.87 5.48 4.73 3.55

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
2.5 50 0 2594.1
1.5 30 0 1161.8
13 Sep 2024 3 30 0 1206.9
18 Sep 2023 3 30 0 1135.55
29 Jul 2022 3 30 0 981.75

Peers

Other companies within the same industry or sector that are comparable to Acutaas Chemicals Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Nitta Gelatin India Ltd 1312.90 -1.19 12.26 2479.35 1071.07 0.00
Sharda Cropchem Ltd 901.20 -7.00 11.94 24637.41 754.66 1.66
Amines and Plasticizers Ltd 194.07 -6.71 31.40 15024.86 372.61 0.26
Indogulf Cropsciences Ltd 60.70 -1.38 10.05 13322.75 49.78 0.00

Company Info

The Company was initially formed as a partnership firm under the Partnership Act, 1932 as "Ami Organics" with effect from January 3, 2004 at Surat, Gujarat, India pursuant to a deed of partnership dated January 3, 2004 executed amongst the Promoters, along with others, as partners. The firm converted into a private limited company under the Companies Act 1956, under the name of "Ami Organics Private Limited" with a certificate of incorporation dated June 12, 2007 issued by the Registrar of Companies, Gujarat, Dadra and Nagar Haveli. Subsequently, the Company was converted into a public limited company, following which the Company's name was changed to "Ami Organics Limited", and a fresh certificate of incorporation was issued by the RoC on April 18, 2018.Major events and milestones of the Company :2004- Formation of partnership firm in the name of "Ami Organics"2007- Ami Organics changed its constitution into Ami Organics Private Limited2011- Implemented the Integrated Management System (IMS)2015- Achieved turnover of Rs. 1,000 million- Incorporated Ami Onco-Theranostics, LLC in USA along with Photolitec LLC2016- Established a tertiary effluent treatment plant to become zero liquid discharge plant- Received recognition from the Department of Scientific and Industrial Research for the in-house research and development ("R&D") unit.2017- Increased warehouse capacity by establishing a warehouse equipped with modern infrastructure including fire and safety and having a storage capacity of 1050 metric ton ("MT") of raw material- Achieved turnover of Rs. 1,500 million- Applied for process patents for five products in India2018- Completed assessment of and established a good manufacturing practice (GMP) compliant facility at the production site and warehouse in Surat, Gujarat.- Applied for process patents for three additional products in India- Converted Ami Organics Private Limited into a public limited company, Ami Organics Limited- Received first establishment inspection report ("EIR") from the United States Food and Drug Administration ("USFDA")2020- Received second EIR from USFDA for the manufacturing facility at Surat, Gujarat- Commencement of a new research and development laboratory at Sachin, Surat, Gujarat- Commencement of the new solvent recovery plant at Sachin, Surat, Gujarat2021- Acquisition of the Ankleshwar and Jhagadia units from Gujarat Organics Limited- Applied for process patents for three additional products in India 2018 -Company name has changed to Ami Organics Ltd. from Ami Organics Pvt. Ltd.. 2025 -Ami Organics Celebrates Full Commissioning of 10.8 MW Solar Power Plant, Driving Sustainability and Cost Savings.

The Company was initially formed as a partnership firm under the Partnership Act, 1932 as "Ami Organics" with effect from January 3, 2004 at Surat, Gujarat, India pursuant to a deed of partnership dated January 3, 2004 executed amongst the Promoters, along with others, as partners. The firm converted into a private limited company under the Companies Act 1956, under the name of "Ami Organics Private Limited" with a certificate of incorporation dated June 12, 2007 issued by the Registrar of Companies, Gujarat, Dadra and Nagar Haveli. Subsequently, the Company was converted into a public limited company, following which the Company's name was changed to "Ami Organics Limited", and a fresh certificate of incorporation was issued by the RoC on April 18, 2018.Major events and milestones of the Company :2004- Formation of partnership firm in the name of "Ami Organics"2007- Ami Organics changed its constitution into Ami Organics Private Limited2011- Implemented the Integrated Management System (IMS)2015- Achieved turnover of Rs. 1,000 million- Incorporated Ami Onco-Theranostics, LLC in USA along with Photolitec LLC2016- Established a tertiary effluent treatment plant to become zero liquid discharge plant- Received recognition from the Department of Scientific and Industrial Research for the in-house research and development ("R&D") unit.2017- Increased warehouse capacity by establishing a warehouse equipped with modern infrastructure including fire and safety and having a storage capacity of 1050 metric ton ("MT") of raw material- Achieved turnover of Rs. 1,500 million- Applied for process patents for five products in India2018- Completed assessment of and established a good manufacturing practice (GMP) compliant facility at the production site and warehouse in Surat, Gujarat.- Applied for process patents for three additional products in India- Converted Ami Organics Private Limited into a public limited company, Ami Organics Limited- Received first establishment inspection report ("EIR") from the United States Food and Drug Administration ("USFDA")2020- Received second EIR from USFDA for the manufacturing facility at Surat, Gujarat- Commencement of a new research and development laboratory at Sachin, Surat, Gujarat- Commencement of the new solvent recovery plant at Sachin, Surat, Gujarat2021- Acquisition of the Ankleshwar and Jhagadia units from Gujarat Organics Limited- Applied for process patents for three additional products in India 2018 -Company name has changed to Ami Organics Ltd. from Ami Organics Pvt. Ltd.. 2025 -Ami Organics Celebrates Full Commissioning of 10.8 MW Solar Power Plant, Driving Sustainability and Cost Savings.

Read More

Parent Organisation

Acutaas Chemicals Ltd.

Founded

12/06/2007

Managing Director

NSE Symbol

ACUTAASEQ

FAQ

The current price of Acutaas Chemicals Ltd is ₹ 2799.10.

The 52-week high for Acutaas Chemicals Ltd is ₹ 2818.70 and the 52-week low is ₹ 2714.50.

The market capitalization of Acutaas Chemicals Ltd is currently ₹ 22916.55. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Acutaas Chemicals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Acutaas Chemicals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Acutaas Chemicals Ltd shares.

The CEO of Acutaas Chemicals Ltd is , who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT